Research Article
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
Table 3
Univariate and multivariate analysis of C2 expression for overall survival in HCC patients of the GSE14520 cohort.
| Variables | Univariate analysis | Multivariate analysis | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value |
| Gender (male vs. female) | 1.68 | 0.81-3.49 | 0.16 | | | | Age (>50 vs. ≤50) | 1.0 | 0.65-1.53 | 0.99 | | | | Cirrhosis (yes vs. no) | 4.57 | 1.13-18.62 | 0.03 | 3.66 | 0.89-14.98 | 0.07 | Main tumor size (>5 cm vs. ≤5 cm) | 1.97 | 1.28-3.30 | 0.002 | 1.18 | 0.69-2.01 | 0.56 | TNM stage (III+IV vs. I+II) | 3.43 | 2.20-6.11 | 0.000 | 2.38 | 1.64-3.46 | 0.000 | C2 (high vs. low) | 0.56 | 0.36-0.87 | 0.01 | 0.73 | 0.47-1.16 | 0.18 |
|
|